NCT07355946Completed
The Effect of Nurse-Led Coaching Program on Self-Care Agency and Quality of Life in Reconstructed Breast Cancer Patients
Source: ClinicalTrials.gov · Last updated 28 May 2026
Brief summary (registry, in English)
The primary objective of this clinical study is to examine the effects of a nurse-led coaching program on self-care agency and quality of life in patients who have undergone reconstructive surgery for breast cancer. 1. Is there a difference in self-care agency between breast reconstructive patients who received a nurse-led coaching program and those who did not? 2. Is there a difference in quality of life between breast reconstructive patients who received a nurse-led coaching program and those who did not? The secondary objective of this clinical study is to determine the satisfaction levels of patients who participated in a nurse-led coaching program for breast reconstructive surgery. The secondary questions the study aims to answer are: 3. What is the satisfaction level of breast reconstructive patients who received a nurse-led coaching program? The researchers will compare whether there are differences in self-care agency and quality of life between breast cancer patients who received a nurse-led coaching program (intervention group) and those who did not (control group). Participants: * Patients who meet the inclusion criteria will be informed of the study's purpose during their postoperative hospital stay, and their informed consent will be obtained. Patients who agree to participate will complete an Introductory Information Form, the Self-Care Agency Scale, and the EORTC QLQ-C30 and QLQ-BR-42 Quality of Life Scales. * After completing the pre-test measurements, the researchers will randomly assign patients to either the control or intervention groups using a random number table. * Patients in the intervention group will receive a routine debriefing on the day of discharge and a total of nine coaching sessions, scheduled weekly for the first 6 weeks and biweekly for the following 6 weeks. These sessions will be conducted via online meeting. * Patients in the control group will receive a routine debriefing only on the day of discharge. * Post-test measurements will be administered to both groups at 12 weeks post-operatively.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 58 (actual)
- First submitted
- 28 Dec 2025
- Start date
- 24 Feb 2025
- Primary completion date
- 1 Dec 2025
- Lead sponsor
- Gazi University
- Diseases
- Childhood cancers
- NCT number
- NCT07355946
What you commit to
- Study type: Interventional
- Participants enrolled: 58
- From 24 Feb 2025 to the primary completion date, 1 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Having a speech, hearing, or vision impairment,
- Having a psychiatric diagnosis or ongoing treatment,
- Having metastatic breast cancer,
- Having a cancer diagnosis other than breast cancer.
Who the study is looking for
- Having undergone breast reconstruction surgery due to breast cancer,
- Being 18 years of age or older,
- Being able to understand and speak Turkish,
- Voluntarily agreeing to participate in the study,
- Being able to read and write.
Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Gazi University Health, Research and Application Center Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.